The α-dystrobrevins play a key role in maintaining the structure and function of the extracellular matrix-significance for protein elimination failure arteriopathies
The α-dystrobrevins play a key role in maintaining the structure and function of the extracellular matrix-significance for protein elimination failure arteriopathies
The extracellular matrix (ECM) of the cerebral vasculature provides a pathway for the flow of interstitial fluid (ISF) and solutes out of the brain by intramural periarterial drainage (IPAD). Failure of IPAD leads to protein elimination failure arteriopathies such as cerebral amyloid angiopathy (CAA). The ECM consists of a complex network of glycoproteins and proteoglycans that form distinct basement membranes (BM) around different vascular cell types. Astrocyte endfeet that are localised against the walls of blood vessels are tethered to these BMs by dystrophin associated protein complex (DPC). Alpha-dystrobrevin (α-DB) is a key dystrophin associated protein within perivascular astrocyte endfeet; its deficiency leads to a reduction in other dystrophin associated proteins, loss of AQP4 and altered ECM. In human dementia cohorts there is a positive correlation between dystrobrevin gene expression and CAA. In the present study, we test the hypotheses that (a) the positive correlation between dystrobrevin gene expression and CAA is associated with elevated expression of α-DB at glial-vascular endfeet and (b) a deficiency in α-DB results in changes to the ECM and failure of IPAD. We used human post-mortem brain tissue with different severities of CAA and transgenic α-DB deficient mice. In human post-mortem tissue we observed a significant increase in vascular α-DB with CAA (CAA vrs. Old p < 0.005, CAA vrs. Young p < 0.005). In the mouse model of α-DB deficiency, there was early modifications to vascular ECM (collagen IV and BM thickening) that translated into reduced IPAD efficiency. Our findings highlight the important role of α-DB in maintaining structure and function of ECM, particularly as a pathway for the flow of ISF and solutes out of the brain by IPAD.
171
Sharp, Matthew MacGregor
b5c70f90-35ba-42df-bbd4-de68c69634ae
Cassidy, Jordan
ddf5a4a5-14fc-404d-aea2-cbe18429f075
Thornton, Thomas
25e6de58-ded7-4fdc-8c47-ef15007a7cae
Lyles, James
2ed95b1d-13c7-49c7-a668-abc182241b00
Keable, Abby
175d97e8-3baf-4130-94a8-f981810e2c96
Gatherer, Maureen
bd7b1066-00cd-4673-82fd-2cec00f1ffc0
Yasui, Masato
be0883f4-f1b1-4d1a-9ef7-111ea60ccd77
Abe, Yoichiro
a2e46723-a2c5-4fb5-a14c-4f45b1944f44
Shibata, Shinsuke
ff78feff-c772-4ee3-9b2e-b4fa83a8727c
Weller, Roy O
4a501831-e38a-4d39-a125-d7141d6c667b
Górecki, Dariusz C
6406abcf-0561-40dc-b41f-32f55795eb04
Carare, Roxana O
0478c197-b0c1-4206-acae-54e88c8f21fa
21 October 2021
Sharp, Matthew MacGregor
b5c70f90-35ba-42df-bbd4-de68c69634ae
Cassidy, Jordan
ddf5a4a5-14fc-404d-aea2-cbe18429f075
Thornton, Thomas
25e6de58-ded7-4fdc-8c47-ef15007a7cae
Lyles, James
2ed95b1d-13c7-49c7-a668-abc182241b00
Keable, Abby
175d97e8-3baf-4130-94a8-f981810e2c96
Gatherer, Maureen
bd7b1066-00cd-4673-82fd-2cec00f1ffc0
Yasui, Masato
be0883f4-f1b1-4d1a-9ef7-111ea60ccd77
Abe, Yoichiro
a2e46723-a2c5-4fb5-a14c-4f45b1944f44
Shibata, Shinsuke
ff78feff-c772-4ee3-9b2e-b4fa83a8727c
Weller, Roy O
4a501831-e38a-4d39-a125-d7141d6c667b
Górecki, Dariusz C
6406abcf-0561-40dc-b41f-32f55795eb04
Carare, Roxana O
0478c197-b0c1-4206-acae-54e88c8f21fa
Sharp, Matthew MacGregor, Cassidy, Jordan, Thornton, Thomas, Lyles, James, Keable, Abby, Gatherer, Maureen, Yasui, Masato, Abe, Yoichiro, Shibata, Shinsuke, Weller, Roy O, Górecki, Dariusz C and Carare, Roxana O
(2021)
The α-dystrobrevins play a key role in maintaining the structure and function of the extracellular matrix-significance for protein elimination failure arteriopathies.
Acta Neuropathologica Communications, 9 (1), , [171].
(doi:10.1186/s40478-021-01274-8).
Abstract
The extracellular matrix (ECM) of the cerebral vasculature provides a pathway for the flow of interstitial fluid (ISF) and solutes out of the brain by intramural periarterial drainage (IPAD). Failure of IPAD leads to protein elimination failure arteriopathies such as cerebral amyloid angiopathy (CAA). The ECM consists of a complex network of glycoproteins and proteoglycans that form distinct basement membranes (BM) around different vascular cell types. Astrocyte endfeet that are localised against the walls of blood vessels are tethered to these BMs by dystrophin associated protein complex (DPC). Alpha-dystrobrevin (α-DB) is a key dystrophin associated protein within perivascular astrocyte endfeet; its deficiency leads to a reduction in other dystrophin associated proteins, loss of AQP4 and altered ECM. In human dementia cohorts there is a positive correlation between dystrobrevin gene expression and CAA. In the present study, we test the hypotheses that (a) the positive correlation between dystrobrevin gene expression and CAA is associated with elevated expression of α-DB at glial-vascular endfeet and (b) a deficiency in α-DB results in changes to the ECM and failure of IPAD. We used human post-mortem brain tissue with different severities of CAA and transgenic α-DB deficient mice. In human post-mortem tissue we observed a significant increase in vascular α-DB with CAA (CAA vrs. Old p < 0.005, CAA vrs. Young p < 0.005). In the mouse model of α-DB deficiency, there was early modifications to vascular ECM (collagen IV and BM thickening) that translated into reduced IPAD efficiency. Our findings highlight the important role of α-DB in maintaining structure and function of ECM, particularly as a pathway for the flow of ISF and solutes out of the brain by IPAD.
Text
s40478-021-01274-8
- Version of Record
More information
Accepted/In Press date: 11 October 2021
Published date: 21 October 2021
Additional Information:
Acknowledgements
Work in the individual CFAS centres is supported by the UK NIHR Biomedical Research Centre for Ageing and Age—awarded to Newcastle-upon-Tyne Hospitals Foundation Trust; Cambridge Brain Bank supported by the NIHR Cambridge Biomedical Research Centre; Nottingham University Hospitals NHS Trust; University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust and the Sheffield NIHR Biomedical Research Centre; The Thomas Willis Oxford Brain Collection, supported by the Oxford Biomedical Research Centre; The Walton Centre NHS Foundation Trust, Liverpool. We would like to acknowledge the essential contribution of the liaison officers, the general practitioners, their staff, and nursing and residential home staff. We are grateful to our respondents and their families for their generous gift to medical research, which has made this study possible.
Identifiers
Local EPrints ID: 452531
URI: http://eprints.soton.ac.uk/id/eprint/452531
ISSN: 2051-5960
PURE UUID: a529e0a6-5f76-4f6f-a33a-f20a1f7d58eb
Catalogue record
Date deposited: 11 Dec 2021 11:26
Last modified: 17 Mar 2024 02:48
Export record
Altmetrics
Contributors
Author:
Matthew MacGregor Sharp
Author:
Jordan Cassidy
Author:
Thomas Thornton
Author:
James Lyles
Author:
Abby Keable
Author:
Maureen Gatherer
Author:
Masato Yasui
Author:
Yoichiro Abe
Author:
Shinsuke Shibata
Author:
Roy O Weller
Author:
Dariusz C Górecki
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics